Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.

Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF; American Society of Clinical Oncology.

J Clin Oncol. 2010 Jul 10;28(20):3388-404. doi: 10.1200/JCO.2009.26.4481. Epub 2010 Jun 7.

PMID:
20530278
[PubMed - indexed for MEDLINE]
3.

Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.

Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG.

Oncol Rep. 1998 Nov-Dec;5(6):1425-9.

PMID:
9769381
[PubMed - indexed for MEDLINE]
4.

[Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].

Neumann A, Keller T, Jocham D, Doehn C.

Aktuelle Urol. 2011 Sep;42(5):311-5. doi: 10.1055/s-0031-1271545. Epub 2011 Aug 1. German.

PMID:
21809268
[PubMed - indexed for MEDLINE]
5.

Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.

Fosså A, Fosså SD.

Br J Urol. 1989 Apr;63(4):408-15.

PMID:
2653557
[PubMed - indexed for MEDLINE]
6.

Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.

Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.

Cancer. 2003 Oct 15;98(8):1635-42.

PMID:
14534879
[PubMed - indexed for MEDLINE]
Free Article
7.

Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy.

Kundu SD, Carver BS, Sheinfeld J.

Urology. 2011 Oct;78(4):844-7. doi: 10.1016/j.urology.2011.02.002. Epub 2011 Jul 22.

PMID:
21782217
[PubMed - indexed for MEDLINE]
8.

Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?

Gerl A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W.

Clin Cancer Res. 1996 Sep;2(9):1565-70.

PMID:
9816334
[PubMed - indexed for MEDLINE]
Free Article
9.

[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].

Müller-Mattheis V, Reinhardt M, Gerharz CD, Fürst G, Vosberg H, Müller-Gärtner HW, Ackermann R.

Urologe A. 1998 Nov;37(6):609-20. German.

PMID:
9887489
[PubMed - indexed for MEDLINE]
10.

Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.

Motawy MS, Szymendera JJ, al-Jazzaf H, Behbehani AE, Foudeh MO, Ebraheem AK, Nasralla MY, Ali MA.

Int J Biol Markers. 1992 Apr-Jun;7(2):80-6.

PMID:
1378875
[PubMed - indexed for MEDLINE]
11.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
[PubMed - indexed for MEDLINE]
12.
13.

Extragonadal germ cell tumors in Japan.

Ebi H, Nakata M, Tahara M, Igarashi T, Kawada K, Itoh K, Ueda R, Minami H.

Cancer Sci. 2003 Dec;94(12):1107-11.

PMID:
14662028
[PubMed - indexed for MEDLINE]
14.

Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.

Otto T, Virchow S, Fuhrmann C, Steinberg F, Streffer C, Goepel M, Rübben H.

Urol Res. 1997;25(2):121-4.

PMID:
9144879
[PubMed - indexed for MEDLINE]
15.

[Systematic review 2007: Primary treatments of testicular germ cell tumors after radical orchydectomy].

Mottet N, Rousmans S, Culine S.

Bull Cancer. 2008 Feb;95(2):205-34. Review. French.

PMID:
18330045
[PubMed - indexed for MEDLINE]
16.

The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.

Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH.

J Urol. 1996 Feb;155(2):587-9.

PMID:
8558665
[PubMed - indexed for MEDLINE]
17.

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.

Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ.

J Clin Oncol. 2001 May 1;19(9):2534-41.

PMID:
11331333
[PubMed - indexed for MEDLINE]
18.

[The role of tumour markers in diagnosis and management of testicular germ cell tumours].

Krege S, Albers P, Heidenreich A.

Urologe A. 2011 Mar;50(3):313-21. doi: 10.1007/s00120-010-2414-5. German.

PMID:
21327901
[PubMed - indexed for MEDLINE]
19.

Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.

von Eyben FE, Blaabjerg O, Hyltoft-Petersen P, Madsen EL, Amato R, Liu F, Fritsche H.

Clin Chem Lab Med. 2001 Jan;39(1):38-44.

PMID:
11256799
[PubMed - indexed for MEDLINE]
20.

Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.

You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Fléchon A.

Urology. 2010 Aug;76(2):423-9.e2. doi: 10.1016/j.urology.2010.02.049. Epub 2010 May 15.

PMID:
20472276
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk